ATE344247T1 - 2-sulfamoylbenzoesäure-derivate - Google Patents

2-sulfamoylbenzoesäure-derivate

Info

Publication number
ATE344247T1
ATE344247T1 AT98924585T AT98924585T ATE344247T1 AT E344247 T1 ATE344247 T1 AT E344247T1 AT 98924585 T AT98924585 T AT 98924585T AT 98924585 T AT98924585 T AT 98924585T AT E344247 T1 ATE344247 T1 AT E344247T1
Authority
AT
Austria
Prior art keywords
acid derivatives
sulfamoylbenzoic acid
thromboxane
leukotriene
receptor
Prior art date
Application number
AT98924585T
Other languages
English (en)
Inventor
Yoshihiro Ichikawa
Tokiko Nishida
Jun Nakano
Mitsuru Watanuki
Masahiro Suda
Tsutomu Nakamura
Original Assignee
Kaken Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharma Co Ltd filed Critical Kaken Pharma Co Ltd
Application granted granted Critical
Publication of ATE344247T1 publication Critical patent/ATE344247T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT98924585T 1997-06-17 1998-06-12 2-sulfamoylbenzoesäure-derivate ATE344247T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17645897 1997-06-17

Publications (1)

Publication Number Publication Date
ATE344247T1 true ATE344247T1 (de) 2006-11-15

Family

ID=16014059

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98924585T ATE344247T1 (de) 1997-06-17 1998-06-12 2-sulfamoylbenzoesäure-derivate

Country Status (11)

Country Link
US (1) US6255321B1 (de)
EP (1) EP0999209B1 (de)
JP (1) JP3527514B2 (de)
KR (1) KR100563430B1 (de)
CN (1) CN1195739C (de)
AT (1) ATE344247T1 (de)
AU (1) AU732106B2 (de)
CA (1) CA2294956A1 (de)
DE (1) DE69836331T2 (de)
ES (1) ES2273419T3 (de)
WO (1) WO1998057935A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7685200A (en) * 1999-10-12 2001-04-23 Kaken Pharmaceutical Co., Ltd. Powdery inhalational preparations and process for producing the same
US7056917B2 (en) * 2001-04-26 2006-06-06 Daiichi Pharmaceutical Co., Ltd. Drug efflux pump inhibitor
JPWO2002087589A1 (ja) * 2001-04-26 2004-08-12 第一製薬株式会社 薬剤排出ポンプ阻害薬
JP2003034681A (ja) * 2001-07-18 2003-02-07 Tosoh Corp N−(ω−ブロモアルキル)フタルイミド類の製造方法
US20080249144A1 (en) * 2004-07-22 2008-10-09 Kaken Pharmaceuitical Co., Ltd. Preventive or Therapeutic Agent for Chronic Inflammatory Lung Disease
AT500990A1 (de) * 2004-10-19 2006-05-15 Hama Foodservice Gmbh Verfahren zur herstellung eines einen fettträger, einen stabilisator bzw. ein geliermittel und ein lösemittel für den stabilisator bzw. das geliermittel enthaltenden nahrungsmittels
JP2011088825A (ja) * 2008-01-16 2011-05-06 Kaken Pharmaceutical Co Ltd 鼻閉症治療用経粘膜投与製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4876346A (en) 1985-05-02 1989-10-24 American Home Products Corporation Quinoline compounds
JPS62142168A (ja) 1985-10-16 1987-06-25 Mitsubishi Chem Ind Ltd チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤
GB8728051D0 (en) 1987-12-01 1988-01-06 Leo Pharm Prod Ltd Chemical compounds
CA2202623A1 (en) 1994-10-14 1996-04-25 Hitoshi Nagaoka Azole derivative
WO1997021691A1 (en) * 1995-12-14 1997-06-19 Kaken Pharmaceutical Co., Ltd. Thiazole derivatives

Also Published As

Publication number Publication date
KR100563430B1 (ko) 2006-03-22
ES2273419T3 (es) 2007-05-01
EP0999209A1 (de) 2000-05-10
AU7674498A (en) 1999-01-04
JP3527514B2 (ja) 2004-05-17
AU732106B2 (en) 2001-04-12
CN1260783A (zh) 2000-07-19
CN1195739C (zh) 2005-04-06
EP0999209B1 (de) 2006-11-02
WO1998057935A1 (en) 1998-12-23
EP0999209A4 (de) 2004-09-15
KR20010013773A (ko) 2001-02-26
DE69836331T2 (de) 2007-05-31
CA2294956A1 (en) 1998-12-23
DE69836331D1 (de) 2006-12-14
US6255321B1 (en) 2001-07-03

Similar Documents

Publication Publication Date Title
TR200002366T2 (tr) Herbisit aktif 3-hidroksi-4-aril-5-oksopirazolin türevleri.
ATE264856T1 (de) Heterocyclisch substituierte benzolderivate und herbizide
CA2311742A1 (en) 6-amino-9-benzyl-8-hydroxypurine derivatives
NO954080D0 (no) Amino(tio)eterderivater
PT897904E (pt) 2-metoxibenzofenonas fungicidas
PT931788E (pt) Inibidores de metaloprotease
ATE350036T1 (de) Tetrahydroquinolin-derivate
NO982606L (no) Naftylsubstituerte benzimidazolderivater som antikoagulanter
PL326024A1 (en) Novel derivatives of cyclodepsipeptidic substance pf1022
NO923721L (no) 4-desoksy-4-epipodophyllotoxin-derivat eller farmasoeytiskakseptabelt salt derav
DE69330639D1 (de) Methotrexat-derivate
EP1426360A4 (de) 2-phenyl-3-heteroaryl propionsäure derivate und deren salze, und diese enthaltende arzneimittel
DE69836331D1 (de) 2-sulfamoylbenzoesäure-derivate
ATE250021T1 (de) Hydroxycyclopentanone
DE69820267D1 (de) Cyclopentenonderivate
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.
DE60039782D1 (de) Amidinophenylbrenztraubensäure-derivat
EP1319658A4 (de) Imidazolderivate oder ihre salze
DE69815347D1 (de) Tetrahydrofuranderivate
EP0729950A4 (de) Anti-hiv arzneimittel
ATE306899T1 (de) 6-alkylindan-1-one als riechstoffe
EP1466909A4 (de) Halogenbenzylaminopropionsäurederivate
NO20040423L (no) Salter av substituerte 1,2,3,4-tetrahydroisokinolin-2-karboksylsyrederivater.
EP1464636A4 (de) Neue substanz mit antitumorwirkung/entzündungshemmender wirkung
BR9901206A (pt) Derivados de pirimidinona.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties